II. Indications

  1. Severe, refractory COPD with Chronic Bronchitis and frequent exacerbations

III. Mechanism

  1. PDE3 and PDE4 Inhibitors increase lung, intracellular cAMP
  2. Bronchodilates and reduces airway inflammation

IV. Medications

  1. Roflumilast (Daliresp) Tablets
  2. Ensifentrine (Ohtuvayre) nebulized

Images: Related links to external sites (from Bing)

Related Studies